Eben Tessari - 01 Sep 2024 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
01 Sep 2024
Net transactions value
-$50,779
Form type
4
Filing time
04 Sep 2024, 20:53:27 UTC
Previous filing
29 Aug 2024
Next filing
25 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Options Exercise +4,499 +3.8% 124,410 01 Sep 2024 Direct F1
transaction KNSA Class A Ordinary Share Tax liability $35,350 -1,322 -1.1% $26.74 123,088 01 Sep 2024 Direct
transaction KNSA Class A Ordinary Share Options Exercise $0 +1,964 +1.6% $0.000000 125,052 02 Sep 2024 Direct
transaction KNSA Class A Ordinary Share Tax liability $15,429 -577 -0.46% $26.74 124,475 02 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Award $0 +6,981 $0.000000 6,981 01 Sep 2024 Class A Ordinary Share 6,981 Direct F1, F2
transaction KNSA Share Option Award $0 +36,300 $0.000000 36,300 01 Sep 2024 Class A Ordinary Share 36,300 $26.74 Direct F3
transaction KNSA Restricted Share Unit Options Exercise $0 -2,726 -33% $0.000000 5,452 01 Sep 2024 Class A Ordinary Share 2,726 Direct F1, F4
transaction KNSA Restricted Share Unit Options Exercise $0 -1,773 -25% $0.000000 5,318 01 Sep 2024 Class A Ordinary Share 1,773 Direct F1, F5
transaction KNSA Restricted Share Unit Options Exercise $0 -1,964 -50% $0.000000 1,964 02 Sep 2024 Class A Ordinary Share 1,964 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F2 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
F3 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
F4 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
F5 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
F6 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021.